Prevalence, incidence, and treatments of Dupuytren's disease in the United States: Results from a population-based study

Hand

Volumn 6, Issue 2, 2011, Pages 149-158

  DiBenedetti, Dana Britt ^a   Nguyen, Dat ^b   Zografos, Laurie ^a   Ziemiecki, Ryan ^a   Zhou, Xiaolei ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b Auxilium Pharmaceuticals   (United States)

Author keywords

Dupuytren's; Epidemiology; Incidence; Prevalence; Survey; Treatment; United States

Indexed keywords

EID: 79955791184     PISSN: 15589447     EISSN: 15589455     Source Type: Journal    
DOI: 10.1007/s11552-010-9306-4     Document Type: Article

References (25)

1. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007; 32: 767-74. doi: 10. 1016/j. jhsa. 2007. 04. 002.
2. Bayat A, Cunliffe EJ, McGrouther DA. Assessment of clinical severity in Dupuytren's disease. Br J Hosp Med. 2007; 68: 604-9. PMID: 18087853.
3. Bergenudd H, Lindgarde F, Nilsson BE. Prevalence of Dupuytren's contracture and its correlation with degenerative changes of the hands and feet and with criteria of general health. J Hand Surg Br. 1993; 18B: 254-7. doi: 10. 1016/0266-7681(93)90123-W.
4. Critchley EM, Vakil SD, Hayward HW, Owen VM. Dupuytren's disease in epilepsy: result of prolonged administration of anticonvulsants. J Neurol Neurosurg Psychiatry. 1976; 39: 498-503. doi: 10. 1136/jnnp. 39. 5. 498.
5. Denkler K. Surgical complications associated with fasciectomy for Dupuytren's disease: a 20-year review of the English literature. J Plast Surg. 2010; 10: 116-33. PMID: 20204055.
6. Early PF. Population studies in Dupuytren's contracture. J Bone Joint Surg Br. 1962; 44B: 602-13.
7. Eckhaus D. Dupuytren's disease. In: Clark GL, Shaw Wilgis EF, Aiello B, et al., editors. Hand rehabilitation: a practical guide. 2nd ed. New York: Churchill Livingstone; 1998. p. 37-42.
8. Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg Br. 2004; 29: 423-6. PMID: 15336742.
9. Greenland S, Rothman KJ. Introduction to stratified analysis. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998. p. 253-79.
10. Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (NY). 2009; 4: 256-69. PMID: 19145463.
11. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009; 361: 968-79. doi: 10. 1056/NEJMoa0810866.
12. Khan AA, Rider OJ, Jayadev CU, Heras-Palou C, Giele H, Goldacre M. The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales. J Hand Surg Br. 2004; 29: 12-4. doi: 10. 1016/j. jhsb. 2003. 08. 012.
13. Knowledge Networks. Methodological information about knowledge networks for reviewers. http://www. knowledgenetworks. com/ganp/reviewer-info. html, accessed 7 July 2009.
14. Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital-a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord. 2007; 8: 60. doi: 10. 1186/1471-2474-8-60.
15. McFarlane RM, MacDermid JC. Dupuytren's disease. In: Mackin EJ, editor. Hunter-Mackin-Callahan rehabilitation of the hand and upper extremity. 5th ed. Philadelphia: Mosby; 2002. p. 971-88.
16. McGrouther DA. Dupuytren's contracture. In: Green DP, Hotchkiss RN, Pederson WC, et al., editors. Green's operative hand surgery. 5th ed. Philadelphia: Churchill Livingstone; 2005. p. 159-85.
17. Rayan GM. Dupuytren's disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007; 89: 189-98. PMID: 17256226.
18. Rayan GM. Nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2008; 33: 1208-10. doi: 10. 1016/j. jhsa. 2008. 05. 027.
19. Rigby AJ, Ma J, Stafford RS. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative. Menopause. 2007; 14: 853-8. doi: 10. 1097/gme. 0b013e3180333a33.
20. Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009; 6: 2133-42. doi: 10. 1111/j. 1743-6109. 2009. 01335. x.
21. Shaw Jr RB, Chong AK, Zhang A, Hentz VR, Chang J. Dupuytren's disease: history, diagnosis, and treatment. Plast Reconstr Surg. 2007; 120: 44e-54e. doi: 10. 1097/01. prs. 0000278455. 63546. 03.
22. US Department of Commerce, Bureau of the Census. Current population survey (CPS). http://www. census. gov/cps/, accessed 29 June 2009.
23. US Department of Commerce, Bureau of the Census. Statistical abstract of the United States: 2010. 129th edition. U. S. Department of Commerce; U. S. Census Bureau; 2010.
24. Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Granger AL, Fehnel SE, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008; 11: 32-43. doi: 10. 1080/13697130701744696.
25. Yost J, Winters T, Fett Sr HC. Dupuytren's contracture: a statistical study. Am J Surg. 1955; 90: 568-71. PMID: 13258948.